Morgan Sanford
Head of Investor Relations, Agios Pharmaceuticals
Replay available
Agios Pharmaceuticals, Inc. (AGIO) Q4 2025 Earnings Call
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) Q4 2025 earnings conference call, held 2026-02-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Brian Gough
Chief Executive Officer
Cecilia Jones
Chief Financial Officer
Sveta Milanova
Chief Commercial Officer
Dr. Sarah Huynh
Chief Medical Officer and Head of Research and Development
Gregory Rinza
Analyst, Truist
Samantha Simonco
Analyst, Citigroup
Alex Stranahan
Analyst, Bank of America
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Agios Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.658 Good morning and welcome to Agios Pharmaceuticals' fourth quarter and full year 2025 00:00:05.658 -- 00:00:11.426 conference call. At this time, all participants are in a listen-only mode. 00:00:11.426 -- 00:00:15.050 There will be a question and answer session at the end. 00:00:15.050 -- 00:00:20.197 Please be advised that this call is being recorded at Agios' request. 00:00:20.197 -- 00:00:25.264 I would now like to turn the call over to Morgan Sanford, head of investor relations 00:00:25.264 -- 00:00:29.246 at Agios. Please go ahead. 00:00:31.267 -- 00:00:33.649 Thank you, operator. Good morning, everyone. 00:00:33.649 -- 00:00:38.675 Thank you for joining us to discuss Agios Pharmaceuticals' fourth quarter and 00:00:38.675 -- 00:00:43.059 full year 2025 financial results and business highlights. 00:00:43.059 -- 00:00:48.165 You can access the slides for today's call by going to the investor section of our website, 00:00:48.165 -- 00:00:50.127 agios.com. 00:00:50.127 -- 00:00:53.230 Please note, we'll be making certain forward-looking statements today. 00:00:53.230 -- 00:00:57.674 Actual events and results could differ materially from those expressed or implied by 00:00:57.674 -- 00:01:02.823 any forward-looking statements because of various risks uncertainties, and other factors, 00:01:02.823 -- 00:01:07.370 including those set forth in our most recent filings with the SEC and any other future 00:01:07.370 -- 00:01:10.535 filings that we may make with the SEC. 00:01:10.535 -- 00:01:15.823 On the call with me today from Agios are Brian Gough, Chief Executive Officer, Cecilia 00:01:15.823 -- 00:01:21.151 Jones, Chief Financial Officer, Sveta Milanova, Chief Commercial Officer, and Dr. 00:01:21.151 -- 00:01:25.738 Sarah Huynh, Chi...